Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2017-05-09 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
关于收购百奥泰康75%股权并对其增资的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the acquisition of 75% equity in Beijing Bio-Tekang Biotechnology Co., Ltd. It includes transaction overview, parties involved, financial data of the target company, terms of the acquisition, payment schedule, governance changes, risk disclosures, and strategic rationale. The content focuses on a capital investment and acquisition transaction rather than financial results, management changes, or regulatory filings. It is not a full annual or interim report, nor an earnings release or call transcript. The document is a formal announcement of a financing and capital structure change through acquisition and equity investment. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2017-05-09 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds through entrusted financial products. It details the amounts, types, and timelines of various financial products purchased and redeemed, including specific figures and dates. The document is relatively short (2052 characters) and focuses on updates about financing activities related to cash management and investment products. There is no indication that this is a full financial report, audit, or earnings release. It is not a regulatory certification or a report publication announcement. The content fits best under Capital/Financing Update (CAP) as it provides updates on the company's financing activities and capital management through entrusted financial products.
2017-05-02 Chinese
关于全资子公司取得不动产权证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding its wholly-owned subsidiary obtaining a property ownership certificate (不动产权证书) for state-owned construction land use rights. It details the land acquisition, contract signing, and certificate issuance. The document is short (1058 characters) and focuses on disclosing a specific asset acquisition event rather than financial results or management changes. It does not contain financial statements or detailed financial analysis. It is not an annual or interim report, audit report, or earnings release. It is not a regulatory filing or certification. It is a formal announcement about a capital asset acquisition, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2017-04-28 Chinese
2017年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2017 年第一季度报告" which translates to "2017 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2017. The report is unaudited as stated in the text. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2017
2017-04-24 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds. It details the company's purchase and redemption of various financial products, including open-ended wealth management products and non-guaranteed floating income products, with specific dates, amounts, and yields. The document is relatively short (2227 characters) and focuses on updates about financing activities related to the company's cash management and investment in financial products. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or interim reports. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The content aligns with updates on company fundraising, financing activities, or capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2017-04-13 Chinese
2016年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2016 annual dividend distribution by the company. It details the dividend per share, relevant dates for dividend distribution, tax treatment, and the shareholder meeting approval date. It does not contain full financial statements or comprehensive financial performance data. The document is focused on dividend amount and payment details, which fits the definition of a Notice of Dividend Amount (DIV). The document length is short (2074 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the appropriate classification is DIV with high confidence.
2017-04-05 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.